Table 3 Prognostic value of mGluR1 expression in clinically relevant breast cancer subgroups.

From: Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer

Subgroups

n

mGluR1 Positive versus Negative

HR

95% CI

p value

ER positive

336

1.23

0.60–2.52

0.577

ER negative

58

7.09

2.17–23.15

0.001

HER2 positive

47

7.26

0.91–58.12

0.062

HER2 negative

347

1.31

0.68–2.53

0.427

TN no

350

1.51

0.75–3.05

0.251

TN yes

44

5.23

1.40–19.60

0.014

  1. Univariate cox-regression analysis of MFS in different breast cancer subgroups (as retrieved from TMA).
Back to article page